Becker's Hospital Review has reported the following six drug or biotech company layoffs in the last two months. They are listed below, beginning with the most recent.
Pharmacy
A proposed bill in New Jersey would ban insurers and pharmacy benefit managers from charging a higher copay than the cash price of a medication, according to New Jersey 101.5, a local radio station.
Two co-pharmacy owners were sentenced to 10 years in prison each for creating a bogus pharmacy to obtain and distribute OxyContin and other prescription narcotics to black-market customers, according to NBC Los Angeles.
Merck, the sole supplier of a critical bladder cancer drug, is restricting shipments of the treatment as demand outpaces supply.
A California jury ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company's talc-based baby powder caused her fatal cancer, according to Bloomberg.
Advertisement
Oral forms of medications include inactive ingredients to help stabilize the drug or aid in its absorption. While these components are usually harmless, nearly all of these pills contain some ingredients that can cause allergic reactions, a new study published…
The chief executive of Novartis' generic drug business Sandoz abruptly stepped down, according to Reuters.
CMS updated its drug spending dashboards with pricing and spending data from 2017 to help increase transparency in healthcare and provide incentives to lower list prices.
Deerfield Management, a healthcare hedge fund, has invested $100 million in a new research and development partnership with Cambridge, Mass.-based Harvard University, according to The Boston Globe.
Purdue Pharma's CEO said a bankruptcy filing is on the table as lawsuits alleging the drugmaker fueled the nation's opioid crisis pile up, according to The Washington Post.